Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

SICKLE CELL DISEASE ASSOCIATION OF AMERICA

Filed by ARTEMIS POLICY GROUP LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 20, 2026
Income
$20,000.00
Expenses
Not reported
Filing UUID
070e6637-f5c0-431f-9bc6-791e593d7e23
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Potential legislation on hospital emergency department care of people with sickle cell disease Education and support for Congressional Sickle Cell Disease Caucus

MMM · Medicare/Medicaid

Engagement with the Center for Medicare and Medicaid Innovation on the Cell & Gene Therapy Access Model Sickle Cell Disease Comprehensive Care Act (S. 721/H.R. 5178) Medicaid eligibility and coverage for needed services for people living with sickle cell disease Implementation of Medicaid Community Engagement provisions of HR 1

Literal federal measure citations: S. 721, H.R. 5178, HR 1

BUD · Budget/Appropriations

Funding for federal sickle cell disease programs Funding and staffing for the CDC Division of Blood Disorders and Public Health Genomics Funding for and continuation of HRSAs Sickle Cell Disease Newborn Screening Follow Up Program FY27 House and Senate Labor-HHS Appropriations

INS · Insurance

Implementation of H.R. 1, One Big Beautiful Bill Act Policies related to Medicaid and ACA Marketplace plans

Literal federal measure citations: H.R. 1

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.